Sickle Cell Disease

• Abnormal Hemoglobin Polymerization and Red Cell Sickling: The glutamic acid-to-valine substitution at the 6th amino acid of the β-globin chain creates a hydrophobic patch on the HbS molecule. Under conditions of deoxygenation, acidosis, or hyperosmolarity, HbS polymerizes into rigid filamentous polymers that distort the RBC into the characteristic sickle shape. This polymerization is reversible initially but becomes fixed with repeated cycles, producing permanently deformed cells. The degree of polymerization correlates directly with HbS percentage (homozygous SS disease shows 85-95% HbS, heterozygous AS trait shows ~40% HbS and typically remains asymptomatic). The polymerization process is temperature-dependent, oxygen-dependent, and pH-dependent, explaining why sickling crises are triggered by infections, hypoxia, dehydration, and acidotic states.

• Vaso-Occlusion and Microvascular Obstruction: Sickled RBCs become rigid and inflexible, losing their normal biconcave disc deformability, preventing passage through microvasculature. These rigid cells adhere abnormally to vascular endothelium through interactions between P-selectin, E-selectin, ICAM-1, and VCAM-1 on endothelial cells and ligands on RBC membranes. Additionally, sickled RBCs express tissue factor and trigger the coagulation cascade, promoting thrombus formation. Vaso-occlusive crises result from mechanical obstruction by sickled RBCs combined with endothelial activation, inflammation (elevated TNF-α, IL-6, IL-8), and hypercoagulability, creating "sickling syndrome" characterized by acute severe pain in bones (particularly femur, humerus, tibia) and organs. The inflammatory response magnifies vaso-occlusion, explaining why NSAIDs and opioids are essential but non-anti-inflammatory analgesics are often insufficient. Recurrent vaso-occlusive episodes cause ischemic infarction of bone marrow, spleen, kidneys, lungs, and brain.

• Chronic Hemolysis and Hemolytic Anemia: Normal RBC lifespan is 120 days; in SCD, RBC survival is reduced to 10-20 days due to splenic sequestration of sickled cells and complement-mediated hemolysis. The rigid, damaged sickle cells are recognized by splenic macrophages and destroyed, leading to compensatory reticulocytosis (often 5-15%) and persistent indirect hyperbilirubinemia. Chronic hemolysis generates chronic anemia (Hb typically 7-10 g/dL in SS disease vs 11-13 g/dL in AS trait), which paradoxically may be protective because higher hemoglobin increases blood viscosity and promotes sickling. The chronically elevated indirect bilirubin predisposes to gallstone disease in up to 50% of patients by young adulthood. Hemolysis also releases hemoglobin into plasma, consuming nitric oxide (NO), which is vasodilatory; NO depletion increases vascularity tone and contributes to pulmonary hypertension, erectile dysfunction, and leg ulcers.

• Splenic Infarction and Functional Asplenia: The spleen is exquisitely vulnerable to sickling due to its low oxygen tension and high metabolic demand. Repeated microinfarcts lead to autosplenectomy by ages 5-8 in homozygous SS disease (spleen becomes a fibrotic remnant), resulting in functional asplenia even when splenomegaly is initially present. Loss of splenic filtration and immune function increases susceptibility to encapsulated organisms (Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis) and Salmonella osteomyelitis. Patients require lifelong prophylactic penicillin, pneumococcal/meningococcal/Hib vaccination, and high clinical suspicion for bacteremia.

• Acute Chest Syndrome Pathogenesis: This life-threatening complication arises from infection (commonly atypical organisms like Chlamydia, Mycoplasma), fat embolism from bone marrow infarction, or in situ sickling in pulmonary microvasculature. The resulting acute lung injury, pulmonary vaso-occlusion, and decreased gas exchange create a vicious cycle: hypoxemia promotes HbS polymerization → increased sickling → increased vaso-occlusion → worsening hypoxemia. Acute chest syndrome can rapidly progress to respiratory failure and death if not recognized and aggressively treated.

• Chronic Organ Damage and "Silent Hypoxemia": Repeated vaso-occlusive episodes and chronic hemolysis cause progressive ischemic damage to multiple organs. Papillary necrosis in the renal medulla (due to low oxygen tension and high ammonia concentration) leads to hematuria, concentrating defects, and chronic kidney disease in 30-50% of patients. Chronic pulmonary hypertension develops in ~1/3 of patients from pulmonary vascular disease and contributes to mortality. Chronic cerebral arterial stenosis (from endothelial proliferation) predisposes to stroke; recurrent subclinical ischemic events detected on MRI ("silent cerebral infarcts") occur in 25-30% of adults and impair cognition. Priapism (prolonged penile erection) occurs from vaso-occlusion of cavernosal vessels and can result in permanent erectile dysfunction if not emergently treated.

• Homozygous HbS Mutation (Sickle Cell Disease, SS Genotype): The autosomal recessive inheritance of the β-globin gene mutation on chromosome 11 (6th codon) produces severe disease only when inherited from both parents. In individuals with SS genotype, virtually 100% of hemoglobin is HbS, resulting in symptomatic disease typically manifesting after age 3-6 months as fetal hemoglobin (HbF) levels decline. Patients of African descent have the highest prevalence (~1 in 365 births in African Americans), though disease also occurs in Mediterranean, Arabian, and Indian populations where malaria was endemic.

• Compound Heterozygous Genotypes (SC, Sβ-Thalassemia): Individuals inheriting one HbS mutation and one other abnormal hemoglobin mutation develop intermediate-severity disease. HbC disease (lysine substituted for glutamic acid at codon 6) creates a milder sickling syndrome with HbSC compound heterozygotes; similarly, Sβ-thalassemia (combining HbS with β-thalassemia trait) produces variable severity depending on β-globin production levels. These genotypes cause 20-40% HbS and manifest with fewer vaso-occlusive crises but remain clinically significant.

• Conditions Promoting HbS Polymerization and Sickling Crises: Various environmental and physiologic triggers precipitate vaso-occlusive episodes, including hypoxia (from respiratory infections, altitude, sedation), dehydration (increasing hemoglobin concentration), infection (bacterial or viral—particularly pneumonia, urinary tract infection, meningitis), acidosis, cold exposure, extreme physical exertion, emotional stress, and female reproductive factors (menstruation, pregnancy, hormonal contraceptives). Pain crises can also occur with no identifiable precipitant. Awareness of triggers guides preventive counseling and crisis prediction.

Acute Presentations

• Vaso-Occlusive Crisis (Pain Crisis): The hallmark acute manifestation, occurring when sickled RBCs obstruct microvasculature and cause ischemic pain. Patients experience acute severe pain in bones (femurs, humeri, tibias most common), chest, back, or abdomen with onset often overnight. The pain is disproportionate to physical findings and responds poorly to NSAIDs alone; severity ranges from mild (managed at home) to unbearable (requiring hospitalization and opioid analgesia). Associated symptoms include low-grade fever (often from inflammation, not infection), tachycardia, tachypnea, and agitation. Dactylitis (hand-foot syndrome) in infants/young children presents as painful swelling of hands and feet with fever, sometimes the first clinical manifestation of SCD. Frequency varies widely—some patients have 1-2 crises yearly while others have 5-10; baseline pain burden is often substantial.

• Acute Chest Syndrome: Presents with fever, cough, dyspnea, and chest pain mimicking pneumonia but with acute worsening despite antibiotics. On examination, patients may have wheezing, rales, or dullness to percussion; chest X-ray shows new infiltrates (usually in lower lobes) that may progress to bilateral involvement. Hypoxemia (often with significant A-a gradient) develops acutely. Defined as new pulmonary infiltrate in a patient with SCD combined with fever, respiratory symptoms, or hypoxemia. Mortality ranges 1-5% even with aggressive treatment; progression to adult respiratory distress syndrome (ARDS) is possible within 24 hours.

• Splenic Sequestration Crisis: Predominantly in children ages 6 months to 5 years (before functional asplenia develops), characterized by sudden splenomegaly, anemia, reticulocytosis, and hypovolemia presenting with pallor, fatigue, abdominal pain, and shock. Rapid transfusion is often life-saving. This crisis typically self-resolves in 7-14 days but recurrence is common; repeated episodes often prompt elective splenectomy.

• Aplastic Crisis: Transient marrow failure (cessation of reticulocytosis) most often triggered by parvovirus B19 infection (erythrovirus), presenting with severe anemia, reticulocytopenia (absolute reticulocyte count drops dramatically despite chronic hemolysis), and symptoms of acute anemia (dyspnea, fatigue, syncope). Hemoglobin may drop 1-2 g/dL per day. Complete resolution occurs within 1-2 weeks as immune clearance eliminates virus and marrow recovers.

• Acute Stroke: Sudden focal neurologic deficit (hemiparesis, speech disturbance, vision loss) from acute arterial occlusion, most commonly affecting middle cerebral artery territory. Occurs in 6-8% of children with SCD and 10% of adults; recurrence rate without treatment is 67-90%. Underlying pathology includes large-vessel arterial stenosis from endothelial proliferation, intimal hyperplasia, and in situ sickling.

• Priapism: Prolonged penile erection (>4 hours, often painful) from vaso-occlusion of cavernosal arteries; can occur in any age (even childhood) and affects 29-42% of males with SCD at some point. Ischemic (low-flow) priapism is most common and is a urologic emergency; stuttering priapism consists of recurrent brief episodes. Untreated episodes lasting >24 hours result in permanent erectile dysfunction from fibrosis and smooth muscle apoptosis.

• Hemolytic Crisis: Acute exacerbation of hemolysis (rare) with increased reticulocytosis, jaundice, and elevated indirect bilirubin, occasionally with hemoglobinuria. Usually associated with concurrent infection or G6PD deficiency in affected patients.

Chronic/Subtle Presentations

• Chronic Anemia: Hemoglobin typically 7-10 g/dL in SS disease; patients maintain reasonable functional capacity due to high 2,3-DPG and leftward-shifted oxygen dissociation curve, but sudden transfusions ("transfusion-related acute lung injury") can worsen oxygenation paradoxically by normalizing hemoglobin and increasing viscosity.

• Leg Ulcers: Chronic, painful, non-healing ulcers over malleoli in 5-10% of patients; pathophysiology involves local sickling, impaired NO bioavailability, and chronic ischemia from vaso-occlusion. Often refractory to standard wound care.

• Osteomyelitis: Atypical for Salmonella species (not typical Staph aureus as in general population); occurs from vaso-occlusive bone infarcts creating sanctuary for organisms. Multiple concurrent sites and vertebral involvement common. Diagnosis challenging because bone pain and elevated markers occur with aseptic infarction as well.

• Gallstones: Up to 50% prevalence by early adulthood from chronic hyperbilirubinemia; usually asymptomatic but cholecystitis can precipitate vaso-occlusive crises.

• Pulmonary Hypertension: Chronic dyspnea, cor pulmonale; detected in ~1/3 of SCD patients and associated with poor prognosis.

• Chronic Kidney Disease: Progressive renal insufficiency from papillary necrosis; up to 50% develop proteinuria and 5-10% reach ESRD. Inability to concentrate urine (from medullary damage) leads to enuresis and polyuria.

• Avascular Necrosis: Aseptic necrosis of femoral head (most common), humeral head, or talus from repeated bone marrow infarcts; presents as sudden joint pain and permanent disability in some patients.

Physical Exam Findings

• Scleral icterus (from chronic hyperbilirubinemia)
• Hepatomegaly and splenomegaly (early in disease, before autosplenectomy)
• Bone tenderness (during crises)
• Systolic ejection murmur (from anemia-induced high cardiac output)
• Tachycardia and tachypnea (chronic compensation for anemia)
• Leg ulcers (over lateral malleoli)
• Priapism (if occurring during evaluation)

• Hemoglobin Electrophoresis or HPLC (High-Performance Liquid Chromatography): Gold standard diagnostic test identifying HbS, HbC, HbF, and other hemoglobins with their percentages. In homozygous SS disease: HbS 85-95%, HbF 0-20% (variable), no HbA (absence of normal hemoglobin is pathognomonic). In heterozygous AS trait: HbS 20-40%, HbA 50-80%, normal or slightly elevated HbF. Electrophoresis demonstrates characteristic bands; HPLC provides quantification. Abnormal results always require reflex to sickle cell solubility test for confirmation if not already performed.

• Sickle Cell Solubility Test (Sickling Test): Rapid, inexpensive screening test using dithionite to deoxygenate hemoglobin; sickled RBCs cause turbidity. Positive in any state with HbS (SS disease, AS trait, SC disease, Sβ-thalassemia). Sensitivities and specificities >95% but cannot differentiate disease from trait—must be followed by electrophoresis. Often used in newborn screening programs.

• Complete Blood Count (CBC) and Peripheral Smear: In SS disease shows normocytic or slightly microcytic anemia (Hb 7-10 g/dL, MCV often 70-90 fL), elevated reticulocyte count (5-25%, indicating brisk compensatory erythropoiesis), and numerous immature RBCs.

Acute vaso-occlusive crisis (first decisions)

• Parenteral opioids: per the NHLBI Evidence-Based Management of Sickle Cell Disease expert panel report, rapid assessment and analgesia within roughly an hour of arrival, using an individualized opioid plan (e.g., morphine or hydromorphone IV, patient-controlled analgesia for severe crises) with adjunctive NSAID (ketorolac) unless renal disease precludes it. Pain is ischemic and inflammatory — undertreatment is the most common error.
• Fluids and oxygen: maintenance-rate isotonic or hypotonic fluids to correct dehydration; avoid aggressive overhydration, which precipitates acute chest syndrome. Supplemental O2 only for hypoxemia (SpO2 below baseline or <95%), since oxygen does not shorten uncomplicated crises.
• Incentive spirometry: reduces progression of chest/back pain crises to acute chest syndrome.

Emergent escalation by syndrome

• Empiric antibiotics for fever ≥38.5 °C: blood culture plus a third-generation cephalosporin (ceftriaxone) immediately — functional asplenia makes pneumococcal sepsis fulminant.
• Acute chest syndrome: cephalosporin plus a macrolide (atypical coverage), bronchodilators, and simple transfusion; exchange transfusion for hypoxemia, multilobar infiltrates, or clinical deterioration.
• Acute stroke: urgent exchange transfusion to reduce HbS to <30% (American Society of Hematology 2020 cerebrovascular guideline); do not delay for thrombolysis decisions.
• Ischemic priapism >4 hours: urologic emergency — cavernosal aspiration and intracavernosal phenylephrine.

Disease-modifying and preventive therapy

• Hydroxyurea: ribonucleotide reductase inhibitor that raises HbF, diluting HbS and blocking polymerization; NHLBI recommends offering it to all children with HbSS from about 9 months of age and to adults with recurrent crises. Also reduces acute chest syndrome and mortality.
• Adjuncts: L-glutamine (reduces oxidant stress) and crizanlizumab (anti–P-selectin monoclonal antibody) reduce crisis frequency in selected patients.
• Prophylaxis: twice-daily oral penicillin V through at least age 5, pneumococcal/meningococcal/Hib and annual influenza vaccination (ACIP), folic acid, and annual transcranial Doppler screening ages 2–16 with chronic transfusion for velocities ≥200 cm/s (STOP trial).
• Curative: allogeneic HSCT from a matched sibling donor; FDA-approved autologous gene therapies (exagamglogene autotemcel, lovotibeglogene autotemcel) for severe disease.

Avoid

• Meperidine (normeperidine accumulation → seizures), transfusing above Hb ~10 g/dL (hyperviscosity), and hydroxyurea in pregnancy (teratogenic).

Emergencies — recognize immediately

• Acute chest syndrome: in-situ pulmonary sickling, infection, or marrow fat embolism creates a hypoxemia → polymerization → more vaso-occlusion spiral. Signaled by new pulmonary infiltrate plus fever, chest pain, or falling SpO2; leading cause of death in adults. Emergency.
• Overwhelming sepsis: autosplenectomy removes opsonin-dependent clearance of encapsulated organisms, so Streptococcus pneumoniae bacteremia can kill within hours. Signaled by fever alone in a child. Emergency.
• Acute ischemic stroke: intimal hyperplasia of the distal ICA/proximal MCA plus sickling. Signaled by any focal deficit or new seizure. Emergency exchange transfusion.
• Splenic sequestration: trapping of sickled cells in a still-functional spleen. Signaled by rapidly enlarging spleen with a falling Hb and rising reticulocyte count plus hypovolemic shock in a toddler. Emergency.
• Aplastic crisis: parvovirus B19 infects erythroid progenitors. Signaled by profound anemia with reticulocytopenia — the reticulocyte count distinguishes it from sequestration. Emergency transfusion if symptomatic.
• Ischemic priapism >4 hours: cavernosal vaso-occlusion; permanent fibrosis and erectile dysfunction follow delay.

Chronic organ damage

• Avascular necrosis of the femoral head: repeated marrow infarction; groin pain with normal early radiographs and MRI marrow edema.
• Proliferative retinopathy: peripheral retinal ischemia and neovascularization — disproportionately common in HbSC; needs annual dilated exams.
• Sickle nephropathy: medullary hypoxia and papillary necrosis → isosthenuria, microalbuminuria, then CKD.
• Pulmonary hypertension: NO scavenging by cell-free hemoglobin; signaled by elevated tricuspid regurgitant jet velocity on echo and rising NT-proBNP, and marks poor prognosis.
• **Pigment gallstones and Salmonella osteomyelitis**: chronic hemolysis and infarcted bone, respectively.

Treatment-related

• Alloimmunization and delayed hemolytic transfusion reaction: signaled by falling Hb days after transfusion with a new antibody; hyperhemolysis drops Hb below pre-transfusion levels — further transfusion worsens it.
• Transfusional iron overload: ferritin and hepatic/cardiac MRI R2* guide chelation (deferasirox, with renal and hepatic monitoring).
• Hydroxyurea myelosuppression and teratogenicity; opioid tolerance and hyperalgesia; GVHD after allogeneic HSCT.

• Fever in a child with SCD is the single highest-yield 'next step': obtain blood cultures and give empiric ceftriaxone immediately — functional asplenia makes pneumococcal sepsis fulminant. Do not wait for a source.
• ***Howell-Jolly bodies* on smear = functional asplenia**: the buzzword that tells you the spleen is gone even when the stem never mentions splenectomy. Pair it with the encapsulated-organism vaccination question.
• Reticulocyte count separates the crises: low retics with severe anemia = parvovirus B19 aplastic crisis; high retics with a big spleen and shock = splenic sequestration; high retics with jaundice = chronic hemolysis.
• **Osteomyelitis in SCD is classically *Salmonella***, though S. aureus remains common overall — this is the association examiners most love to test. Distinguishing infarction from infection usually requires MRI.
• New infiltrate + fever/hypoxemia = acute chest syndrome, not simple pneumonia: the next step is CXR, antibiotics covering atypicals, and transfusion (exchange if hypoxemic). It is the leading cause of death in adults.
• Hydroxyurea works by raising HbF, which dilutes HbS below the polymerization threshold; it reduces crises, acute chest syndrome, and mortality. Expected labs: rising MCV and mild neutropenia — signs of adherence, not toxicity.
• **Sickle trait is not a mild disease — it is asymptomatic. The exam-relevant exceptions are painless hematuria/isosthenuria from papillary necrosis, exertional rhabdomyolysis, and renal medullary carcinoma**. Do not start hydroxyurea or penicillin for trait.

Common distractors to avoid

• Transfusing to a normal hemoglobin: raising Hb much above ~10 g/dL increases viscosity and worsens vaso-occlusion. Target modest correction or use exchange transfusion.
• Meperidine for pain: normeperidine accumulation causes seizures; choose morphine or hydromorphone.
• Oxygen for every crisis: give it only for documented hypoxemia; it does not shorten an uncomplicated painful episode.
• Diagnosing SCD with a solubility (sickling) test: it is positive in trait and disease alike — hemoglobin electrophoresis/HPLC is required to distinguish them.